{"id":"https://openalex.org/A5117066013","orcid":"https://orcid.org/0009-0003-3391-5266","observed_orcids":["https://orcid.org/0009-0003-3391-5266"],"display_name":"Jone Etxaniz-D\u00edaz de Durana","raw_author_names":["Jone Etxaniz-Diaz de Durana","Jone Etxaniz-D\u00edaz de Durana"],"full_name":"Jone Etxaniz-Diaz de Durana","works_count":17,"cited_by_count":21,"summary_stats":{"2yr_mean_citedness":1.2352941176470589,"h_index":3,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117066013","orcid":"https://orcid.org/0009-0003-3391-5266","observed_orcids":["https://orcid.org/0009-0003-3391-5266"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210112728","ror":"https://ror.org/02x5c5y60","display_name":"CIC bioGUNE","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210112728"]},"years":[2026,2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210112728","ror":"https://ror.org/02x5c5y60","display_name":"CIC bioGUNE","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210112728"]}],"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","count":15,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":15,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","count":8,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":5,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10602","display_name":"Glycosylation and Glycoproteins Research","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","value":6.42e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12387","display_name":"Galectins and Cancer Biology","value":4.88e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":3.37e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","value":2.14e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","value":1.07e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","score":0.6215000152587891},{"id":"8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","score":0.6022999882698059},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.592667281627655},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.49239999055862427},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.3149906098842621}],"counts_by_year":[{"year":2025,"works_count":16,"oa_works_count":15,"cited_by_count":8},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":13}],"display_name_alternatives":["Jone Etxaniz-Diaz de Durana","Jone Etxaniz-D\u00edaz de Durana"],"block_key":"j durana","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117066013","updated_date":"2026-11-07T12:08:38","created_date":"2025-04-08T00:00:00"}
